강현구 (부산대학교) | 한빛사논문 > 한빛사

한빛사논문

조회763

부산대학교

CV File 312 kb

Cell Rep. Med., Published:January 04, 2023 | https://doi.org/10.1016/j.xcrm.2022.100880 DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma

Hyunkoo Kang,^1,9 Haksoo Lee,^1,9 Kyeongmin Kim,² Eunguk Shin,¹ Byeongsoo Kim,¹ JiHoon Kang,³ Bohkyung Kim,⁴ Jung Sub Lee,⁵ Jae-Myung Lee,⁶ HyeSook Youn,⁷ and BuHyun Youn^1,8,10,*

¹Department of Integrated Biological Science, Pusan National University, Busan 46241, Republic of Korea
²Center Research Institute, Samjin Pharm. Co., Ltd, Seoul 07794, Republic of Korea
³Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, GA
30322, USA
⁴Department of Food Science and Nutrition, Pusan National University, Busan 46241, Republic of Korea
⁵Department of Orthopaedic Surgery, Biomedical Research Institute, Pusan National University Hospital, Pusan National University School of
Medicine, Busan 49241, Republic of Korea
⁶Department of Naval Architecture and Ocean Engineering, Pusan National University, Busan 46241, Republic of Korea
⁷Department of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Republic of Korea
⁸Department of Biological Sciences, Pusan National University, Busan 46241, Republic of Korea
⁹These authors contributed equally
¹⁰Lead contact

^*Correspondence: BuHyun Youn

Abstract

Glioblastoma (GBM) currently has a dismal prognosis. GBM cells that survive radiotherapy contribute to tumor progression and recurrence with metabolic advantages. Here, we show that diacylglycerol kinase B (DGKB), a regulator of the intracellular concentration of diacylglycerol (DAG), is significantly downregulated in radioresistant GBM cells. The downregulation of DGKB increases DAG accumulation and decreases fatty acid oxidation, contributing to radioresistance by reducing mitochondrial lipotoxicity. Diacylglycerol acyltransferase 1 (DGAT1), which catalyzes the formation of triglycerides from DAG, is increased after ionizing radiation. Genetic inhibition of DGAT1 using short hairpin RNA (shRNA) or microRNA-3918 (miR-3918) mimic suppresses radioresistance. We discover that cladribine, a clinical drug, activates DGKB, inhibits DGAT1, and sensitizes GBM cells to radiotherapy in vitro and in vivo. Together, our study demonstrates that DGKB downregulation and DGAT1 upregulation confer radioresistance by reducing mitochondrial lipotoxicity and suggests DGKB and DGAT1 as therapeutic targets to overcome GBM radioresistance.

논문정보

형식Research article
게재일2023년 01월 (BRIC 등록일 2023-01-11)
연구진국내(교신)+국외 연구진
분야 생명과학 > 노화/암생물학

댓글 작성 로그인

CV 열람하기

연락처 보기